D. He

发表

Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway

Jing He, Yahui Liao, Houwen Lin, 2022, OncoTargets and therapy.

Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo

V. Golubovskaya, W. Cance, N. Massoll, 2009, Cell cycle.

Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo.

A. Magis, S. Sebti, S. Hochwald, 2013, Anti-cancer agents in medicinal chemistry.

Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.

A. Magis, W. Cance, D. Ostrov, 2009, Journal of medicinal chemistry.

A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells

S. Hochwald, M. Zajac-Kaye, Jianliang Zhang, 2014, Cell cycle.

Abstract 1921: A novel FAK kinase inhibitor (PF-4554878) decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells

S. Hochwald, Shun Lu, M. Zajac-Kaye, 2012 .

Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian Carcinoma.

Y. Duan, Chuanrong Chen, K. Gong, 2021, Journal of biomedical nanotechnology.

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer

Ke Gong, Y. Duan, Fangfang Liu, 2022, Journal of Nanobiotechnology.

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

Ming Yan, Ping Zhang, Qin Xu, 2009, BMC Cancer.

The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer

Ke Gong, Chao-qun Xu, Y. Duan, 2021, Journal of Nanobiotechnology.

OTT_A_340556 87..101

Jing He, Yahui Liao, Houwen Lin, 2022 .

The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth

W. Bshara, M. Seshadri, W. Cance, 2013, Oncotarget.

Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO

Ping Zhang, D. Ye, Zhiyuan Zhang, 2007, BMC Cancer.

[Inflammatory factors promote oral squamous cell carcinoma cells metastasis, via nuclear factor kappa B signal pathway in vitro].

Ming Yan, Ping Zhang, Wantao Chen, 2010, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma.

S. Hochwald, D. Ostrov, D. Ucar, 2011, Anti-cancer agents in medicinal chemistry.